Essential thrombocythemia in young adults: Major thrombotic complications and complications during pregnancy - A follow-up study in 68 patients

Clinical and Applied Thrombosis/Hemostasis

Volumn 6, Issue 1, 2000, Pages 31-35

  Randi, Maria Luigia ^a   Rossi, Carla ^a   Fabris, Fabrizio ^a   Girolami, Antonio ^a  

^a UNIVERSITY OF PADUA MEDICAL SCHOOL   (Italy)

Author keywords

Essential thrombocythemia; Myeloproliferative disorders; Thrombosis

Indexed keywords

ACETYLSALICYLIC ACID;

ADULT; ARTICLE; ATHEROSCLEROSIS; DOSE RESPONSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYELOPROLIFERATIVE DISORDER; OUTCOMES RESEARCH; POLYCYTHEMIA VERA; PREGNANCY COMPLICATION; PRIORITY JOURNAL; RISK FACTOR; THROMBOCYTE COUNT; THROMBOCYTHEMIA; THROMBOSIS;

ACUTE DISEASE; ADULT; AGE FACTORS; ARTERIOSCLEROSIS; ASPIRIN; BUSULFAN; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HEPARIN; HUMANS; HYDROXYUREA; LEUKEMIA; MALE; MYELOFIBROSIS; PREGNANCY; PREGNANCY COMPLICATIONS, CARDIOVASCULAR; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PREGNANCY OUTCOME; PROSPECTIVE STUDIES; RISK FACTORS; SPLENECTOMY; THROMBOCYTHEMIA, HEMORRHAGIC; VENOUS THROMBOSIS; WARFARIN;

EID: 0033979528     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602960000600105     Document Type: Article

References (31)

1. Tefferi A, Hoagland HC. Issues in the diagnosis and menagement of essential thrombocythemia. Mayo Clinic Proc 1994;69:651.
2. Mitus AJ, Barbui T, Shulman L, et al. Hemostatic complications in young patients with essential thrombocythemia. Am J Med 1990; 88:371.
3. Hoagland HC, Silverstein MN. Primary thrombocythemia in the young patients. Mayo Clin Proc 1978;53:578.
4. Randi ML, Fabris F, Girolami A. Thrombocytosis in young people: evaluation of 57 cases diagnosed before the age of 40. Blut 1990; 60:233.
5. Rossi C, Randi ML, Zerbinati P, et al. Acute coronary disease in essential thrombocythemia and polycythemia vera. J. Intern Med 1998;244:49.
6. Randi ML, Fabris F, Cella G, et al. Cerebral vascular accidents in young patients with essential thrombocythemia: relation with other known cardiovascular risk factors. Angiology 1998;49:477.
7. Murphy MF, Clarke CR, Brearley RL. Superior sagittal sinus thrombosis and essential thrombocythemia. Br Med J 1983;287: 1344.
8. Randi ML, Rossi C, Barbone E, et al. Superior sagittal sinus thrombosis in 5 patients with essential thrombocythemia: a possible disease variant. Rev Iberoamer Tromb Hemostasia 1994;7:76.
9. Valla D, Casadevall N, Macombe C, et al. Primary myeloproliferative disorders and hepatic vein thrombosis. Ann Intern Med 1985;103:329.
10. Van Genderen PJJ, Michiels JJ. Primary thrombocythemia: diagnosis, clinical manifestations and management. Ann Haematol 1993;67:57.
11. Watson KV, Key N. Vascular complications in essential thrombocythemia: a link to cardiovascular risk factors. Br J Haematol 1993;83:198.
12. Murphy S, Iland H, Rosenthal D, et al. Essential thrombocythemia: an interim report from the polycythemia vera study group. Semin Haematol 1986;23:177.
13. Kessler CM, Klein HG, Havlik RJ. Uncontrolled thrombocytosis in chronic myeloproliferative disorders. Br J Haematol 1982;50:157.
14. Mc Intyre KJ, Hoagland HC, Silverstein MN, et al. Essential thrombocythemia in young adults. Mayo Clin Proc 1991;66:149.
15. Randi ML, Fabris F, Rossi C, et al. Sex and age as prognostic factors in essential thrombocythemia. Haematologica 1992;77-402.
16. Millard FE, Hunter CS, Anderson M, et al. Clinical manifestations of essential thrombocythemia in young adults. Am J Hematol 1990; 33:27.
17. Frezzato M, Ruggeri M, Castaman G, et al. Polycythemia vera and essential thrombocythemia in young patients. Haematologica 1993;78:11.
18. Davis RB. Acute thrombotic complications of myeloproliferative disorders in young adults. Am J Clin Pathol 1985;84:180.
19. Van Genderen PJJ, Michiels JJ, Van Strik R, et al. Platelet consumption in thrombocythemia complicated by erythromelalgia: reversal by aspirin. Thromb Haemost 1995;73:210.
20. Fenaux P, Simon M, Caulier MT, et al. Clinical course of essential thrombocythemia in 147 cases. Cancer 1990;66:549.
21. Barosi G, Ambrosetti A, Buratti A, et al. Splenectomy in myelofibrosis with myeloid metaplasia: pretreatment variables and outcome prediction. Leukemia 1993;7:200.
22. Cortellazzo S, Viero P, Finazzi G, et al. Incidence and risk factors for thrombotic complications in a historical cohort of 100 patients with essential thrombocythemia. J Clin Oncol 1990;8:556.
23. Beard J, Hillmen P, Anderson CC, et al. Primary thrombocythemia in pregnancy. Br J Haematol 1991;77:371.
24. Falconer J, Pineo G, Blahey W, et al. Essential thrombocythemia associated with recurrent abortions and fetal growth retardation. Am J Hematol 1987;25:345.
25. Bellucci S, Janvier M, Tobelem G, et al. Essential thrombocythemia: clinical, evolutionary and biological data. Cancer 1986;58: 2440.
26. Mercer B, Drouin J, Jolly E, et al. Primary thrombocythemia in pregancy: a report of two cases. Am J Obstet Gynecol Reprod Biol 1991;40:237.
27. Randi ML, Barbone E, Rossi C, et al. Essential thrombocythemia and pregnancy: a report of six normal pregnancies in five untreated patients. Obstet Gynecol 1994;83:915.
28. Beressi AH, Tefferi A, Silverstein MN, et al. Outcome analysis of 34 pregnancies in women with essential thrombocythemia. Arch Intern Med 1995;155:1217.
29. Radaelli F, Colombi M, Maiolo AT. Essential thrombocythemia in pregnacy: report of four cases. Haematologica 1994;79:360.
30. Gruppo Italiano Studio Policitemia Vera. Polycythemia Vera: The natural history on 1213 patients followed for 20 years. Ann Intern Med 1995;123:656.
31. Van Genderen PJJ, Mulder PGH, Waleboer M, et al. Prevention and treatment of thrombotic complications in essential thrombocythemia: efficacy and safety of aspirin. Br J Haematol 1997;97: 179.